Your trusted source for investing success

Tag: california

Otis Appoints Mr. Michael Vint to Advisory Board

Otis Appoints Mr. Michael Vint to Advisory Board

Otis Gold Corp.  (TSXV:OOO) is pleased to announce the appointment of Mr. Michael Vint to its Advisory Board. Mr. Vint is a Vice President of Endeavour Financial Ltd., responsible for technical reviews and assessment of mining projects worldwide. Endeavour is focused on structured finance, project financing and M&A in the natural

BioSig Technologies Provides Shareholder Update

BioSig Technologies Provides Shareholder Update

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet technology need for the $4 billion electrophysiology (EP) marketplace, today provided a shareholder update and highlighted the company’s recent achievements it has reached during the first part of

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it has entered into a three-year collaboration with Duke University to evaluate VAL-083, the Company’s platform compound, as a front-line treatment for newly diagnosed patients with glioblastoma multiforme (“GBM”).

IGEN Networks Files 2016 Annual Report

IGEN Networks (CSE:IGN; OTCQB:IGEN) has reported that it has filed its 2016 annual report.

As quoted in the press release:
In 2016, IGEN continued to focus its efforts on generating more revenues, increasing shareholder value through increased investment or acquisition in portfolio companies, and managing growth of its invested companies.

Financial highlights reported

Vodis Closes Private Placement

Vodis Closes Private Placement

Vodis Pharmaceuticals Inc. (CSE: VP / FSE: 1JV1) (“Vodis” or the “Company”) is pleased to announce it has closed a non-brokered private placement of 4,000,000 units (each, a “Unit”) of the Company at a price of $0.40 for total gross proceeds of $1,600,000. Each Unit will comprise one common share

Lexaria Welcomes Canada’s Proposed Cannabis Legislation

Lexaria Welcomes Canada’s Proposed Cannabis Legislation

Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) welcomes the newly proposed Canadian legislation designed to allow for adult legal access to Cannabis (the “Cannabis Act”). In line with the Cannabis Act’s objective to protect public health and public safety, powerful demographic and lifestyle forces are trending away from both the harmful effects related

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network